117 related articles for article (PubMed ID: 38048899)
21. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
[TBL] [Abstract][Full Text] [Related]
22. Research on the Application Value of Serum and Urine β2-Microglobulin in Immunoglobulin a Nephropathy.
Ren L; Zhang C; Wen W; Pan Y; Chen H; Sun W; Sun J
Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658435
[TBL] [Abstract][Full Text] [Related]
23. Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy.
Li G; Wang X; Yang Z; Zhao Q; Wen Y; Li X; Gao R
Dis Markers; 2019; 2019():9802839. PubMed ID: 31354895
[TBL] [Abstract][Full Text] [Related]
24. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
[TBL] [Abstract][Full Text] [Related]
25. Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy.
Ji FP; Wen L; Zhang YP; Liu EP; Wen JG
Int Urol Nephrol; 2022 Jun; 54(6):1287-1294. PubMed ID: 34585312
[TBL] [Abstract][Full Text] [Related]
26. Serum TNF-
Wu H; Wen Y; Yue C; Li X; Gao R
Dis Markers; 2020; 2020():5514145. PubMed ID: 33299497
[TBL] [Abstract][Full Text] [Related]
27. Elevated serum HE4 levels as a novel biomarker of disease severity and hepatic fibrosis in autoimmune hepatitis.
Yu Z; Nian C; Sun W; Liu X; Nian X
Clin Chim Acta; 2024 Jun; 559():119682. PubMed ID: 38643819
[TBL] [Abstract][Full Text] [Related]
28. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
29. The features in IgA-dominant infection-related glomerulonephritis distinct from IgA nephropathy: a single-center study.
Handa T; Kakita H; Tateishi Y; Endo T; Suzuki H; Katayama T; Tsukamoto T; Muso E
Clin Exp Nephrol; 2018 Oct; 22(5):1116-1127. PubMed ID: 29564665
[TBL] [Abstract][Full Text] [Related]
30. Human Epididymis Protein 4 as a Potential Biomarker of Chronic Kidney Disease in Female Patients With Normal Ovarian Function.
Yuan T; Li Y
Lab Med; 2017 Aug; 48(3):238-243. PubMed ID: 28934517
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Torun Bayram M; Heybeli C; Yıldız G; Soylu A; Celik A; Sarioglu S; Kavukçu S
Int Urol Nephrol; 2022 Aug; 54(8):1925-1932. PubMed ID: 34846620
[TBL] [Abstract][Full Text] [Related]
32. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
33. DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy.
Chen J; Hu W; Xiao F; Lin L; Chen K; Wang L; Wang X; He Y
Kidney Blood Press Res; 2019; 44(5):1063-1074. PubMed ID: 31487717
[TBL] [Abstract][Full Text] [Related]
34. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
Bagchi S; Lingaiah R; Mani K; Barwad A; Singh G; Balooni V; Bhowmik D; Agarwal SK
PLoS One; 2019; 14(3):e0214256. PubMed ID: 30917188
[TBL] [Abstract][Full Text] [Related]
35. Elevated Endostatin Expression Is Regulated by the pIgA Immune Complex and Associated with Disease Severity of IgA Nephropathy.
Zhai Y; Long X; Gao J; Yao X; Wang X; Zhao Z
Kidney Blood Press Res; 2021; 46(1):31-40. PubMed ID: 33341801
[TBL] [Abstract][Full Text] [Related]
36. Association between geriatric nutritional risk index and pathological phenotypes of IgA nephropathy.
Gan Y; Li J; Wu J; Zhang R; Han Q; Li Z; Yang Q
PeerJ; 2023; 11():e14791. PubMed ID: 36815992
[TBL] [Abstract][Full Text] [Related]
37. Positive association of serum FUT8 activity with renal tubulointerstitial injury in IgA nephropathy patients.
Yang N; Li LK; He H; Guo XN; Yuan XF; Li ZT; Wang WD; Qin BJ; Du XN; Zhang X; Chen SN; Lin HL
Immun Inflamm Dis; 2022 Sep; 10(9):e686. PubMed ID: 36039648
[TBL] [Abstract][Full Text] [Related]
38. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
Yanagawa H; Suzuki H; Suzuki Y; Kiryluk K; Gharavi AG; Matsuoka K; Makita Y; Julian BA; Novak J; Tomino Y
PLoS One; 2014; 9(5):e98081. PubMed ID: 24858067
[TBL] [Abstract][Full Text] [Related]
39.
Dotz V; Visconti A; Lomax-Browne HJ; Clerc F; Hipgrave Ederveen AL; Medjeral-Thomas NR; Cook HT; Pickering MC; Wuhrer M; Falchi M
J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
[TBL] [Abstract][Full Text] [Related]
40. Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study.
Bi TD; Zheng JN; Zhang JX; Yang LS; Liu N; Yao L; Liu LL
BMC Nephrol; 2019 Jul; 20(1):244. PubMed ID: 31272400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
